Breast, lung, colon and rectum, prostate, skin, and stomach cancer were the commonly seen types in the region. According to the WHO data, ~1.20 million of the new cases reported in 2020 were skin cancer cases. Skin cancer is by far the most common of all cancer types. Melanoma and non-melanoma are the two types of skin cancer. Although melanoma accounts for ~1% of total skin cancer cases, it causes maximum skin cancer deaths. The incidence rate of melanoma has rapidly increased in the past few decades, and it varies with age. According to the Skin Cancer Foundation, during 2012–2022, annual diagnosis for invasive melanoma cases increased by 31%. Thus, the incidence of skin cancer is likely to increase in the coming years leading to higher demand for skin cancer diagnostics.
With the new features and technologies, vendors attract new customers and expand their footprints in emerging markets. This factor is driving the growth of the South & Central America skin cancer diagnostics market at a promising CAGR.
South & Central America Skin Cancer Diagnostics Market Revenue And Forecast To 2028 (US$ Million)
The skin cancer diagnostics market is segmented into type and screening type. Based on type, the market is segmented into melanoma and non-melanoma. Based on screening type, the market is segmented into skin biopsy, dermatoscopy, lymph node biopsy, imaging tests, and blood tests. Based on country, the skin cancer diagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America
AMLo Biosciences Limited; DermLite LLC; bioMerieux SA; Hoffmann-La Roche Ltd.; and Michelson Diagnostics Ltd. are among the leading companies in the South & Central America skin cancer diagnostics market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 234.3 Million |
| Market Size by 2028 | US$ 338.6 Million |
| CAGR (2021 - 2028) | 5.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South and Central America Skin Cancer Diagnostics Market is valued at US$ 234.3 Million in 2021, it is projected to reach US$ 338.6 Million by 2028.
As per our report South and Central America Skin Cancer Diagnostics Market, the market size is valued at US$ 234.3 Million in 2021, projecting it to reach US$ 338.6 Million by 2028. This translates to a CAGR of approximately 5.4% during the forecast period.
The South and Central America Skin Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Skin Cancer Diagnostics Market report:
The South and Central America Skin Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Skin Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Skin Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Skin Cancer Diagnostics Market
